发明名称 Benzenesulfonamide derivatives as antipsychotic agents
摘要 The invention provides compounds of formula (I) wherein A and B represent the groups -(CH<SUB>2</SUB>)<SUB>m</SUB>- and -(CH<SUB>2</SUB>)<SUB>n</SUB>-respectively; R<SUP>1 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>2 </SUP>represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxyC<SUB>1-6</SUB>alkyl, trifluoromethyl, trifluoromethoxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>alkoxyC<SUB>1-6</SUB>alkyl, C<SUB>3-7</SUB>cycloalkylC<SUB>1-6</SUB>alkoxy, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyloxy, -COC<SUB>1-6</SUB>alkyl, -SO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -SOC<SUB>1-6</SUB>alkyl, -S-C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkylsulfonyloxy, C<SUB>1-6</SUB>alkylsulfonylC<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, -SO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, C<SUB>1-6</SUB>alkylsulfonamido, C<SUB>1-6</SUB>alkylsulfonamidoC<SUB>1-6</SUB>alkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, C<SUB>1-6</SUB>alkylamidoC<SUB>1-6</SUB>alkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>7</SUP>COR<SUP>8</SUP>, arylsulfonyl, arylsulfonyloxy, arylsulfonylC<SUB>1-6</SUB>alkyl, arylsulfonamido, arylcarboxamido, arylsulfonamidoC<SUB>1-6</SUB>alkyl, arylcarboxamidoC<SUB>1-6</SUB>alkyl, aroyl, aroylC<SUB>1-6</SUB>alkyl, arylC<SUB>1-6</SUB>alkanoyl, -SO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8</SUP>, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heterocyclyl, or a group CONR<SUP>7</SUP>R<SUP>8 </SUP>or SO<SUB>2</SUB>NR<SUP>7</SUP>R<SUP>8 </SUP>wherein R<SUP>7 </SUP>and R<SUP>8 </SUP>together may be fused to form a 5- 7-membered aromatic or non-aromatic heterocyclic ring optionally interrupted by an O or S atom; R<SUP>3 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; Ar represents optionally substituted phenyl or optionally substituted monocyclic heteroaryl group; R<SUP>4 </SUP>represents optionally substituted aryl or optionally substituted heteroaryl; R<SUP>7 </SUP>and R<SUP>8 </SUP>each independently represent hydrogen, C<SUB>1-6</SUB>alkyl or together form a 5- to 7-membered heterocyclic ring; Z represents a bond, an oxygen atom or C<SUB>1-6</SUB>alkyl; Y represents hydrogen or C<SUB>1-6</SUB>alkyl; m and n independently represent an integer selected from 1 and 2; p independently represents an integer selected from 0, 1, 2 and 3; q represents an integer from 1 to 3; r represents an integer from 1 to 4; or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful in therapy, in particular as antipsychotic agents.
申请公布号 US2005222124(A1) 申请公布日期 2005.10.06
申请号 US20050504111 申请日期 2005.03.15
申请人 BROMIDGE STEVEN M;COOPER DAVID G;FORBES IAN T;GRIBBLE ANDREW D;JOHNSON CHRISTOPHER N;PLIGHTFOOT ANDREW;MOSS STEPHEN F;PAYNE ANDREW H;RAHMAN SHAHZAD S;WITTY DAVID R 发明人 BROMIDGE STEVEN M.;COOPER DAVID G.;FORBES IAN T.;GRIBBLE ANDREW D.;JOHNSON CHRISTOPHER N.;PLIGHTFOOT ANDREW;MOSS STEPHEN F.;PAYNE ANDREW H.;RAHMAN SHAHZAD S.;WITTY DAVID R.
分类号 A61K31/40;A61K31/4035;A61K31/47;A61K31/472;A61K31/55;A61P1/08;A61P3/04;A61P15/10;A61P25/00;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;C07D209/44;C07D217/02;C07D217/04;C07D223/16;C07D401/10;C07D401/12;C07D403/10;C07D403/12;C07D405/12;C07D407/10;C07D409/10;C07D409/12;C07D413/10;C07D413/12;(IPC1-7):A61K31/55 主分类号 A61K31/40
代理机构 代理人
主权项
地址